Literature DB >> 21306243

Promising advances in the treatment of malignant pancreatic endocrine tumors.

Robert T Jensen, Gianfranco Delle Fave.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21306243     DOI： 10.1056/NEJMe1013903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Cancer: a roadmap for the land of small tumors.

Authors:  Robert T Jensen
Journal:  Nat Rev Endocrinol       Date:  2011-04-26       Impact factor: 43.330

2.  Preoperative assessment of nonfunctioning pancreatic endocrine tumours: role of MDCT and MRI.

Authors:  Giovanni Foti; Letizia Boninsegna; Massimo Falconi; Roberto Pozzi Mucelli
Journal:  Radiol Med       Date:  2013-07-25       Impact factor: 3.469

3.  Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours.

Authors:  Samer Ezziddin; Feras Khalaf; Maria Vanezi; Torjan Haslerud; Karin Mayer; Abdullah Al Zreiqat; Winfried Willinek; Hans-Jürgen Biersack; Amir Sabet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-07       Impact factor: 9.236

4.  Real-world study of everolimus in advanced progressive neuroendocrine tumors.

Authors:  Francesco Panzuto; Maria Rinzivillo; Nicola Fazio; Filippo de Braud; Gabriele Luppi; Maria Chiara Zatelli; Francesca Lugli; Paola Tomassetti; Ferdinando Riccardi; Carmen Nuzzo; Maria Pia Brizzi; Antongiulio Faggiano; Alberto Zaniboni; Elisabetta Nobili; Davide Pastorelli; Stefano Cascinu; Marco Merlano; Silvana Chiara; Lorenzo Antonuzzo; Chiara Funaioli; Francesca Spada; Sara Pusceddu; Annalisa Fontana; Maria Rosaria Ambrosio; Alessandra Cassano; Davide Campana; Giacomo Cartenì; Marialuisa Appetecchia; Alfredo Berruti; Annamaria Colao; Massimo Falconi; Gianfranco Delle Fave
Journal:  Oncologist       Date:  2014-08-12

5.  [Medicinal therapy of metastasized neuroendocrine tumors of the gastroenteropancreatic system.]

Authors:  C J Auernhammer; C Spitzweg; V Heinemann; B Göke
Journal:  Internist (Berl)       Date:  2012-02-02       Impact factor: 0.743

Review 6.  Therapy for metastatic pancreatic neuroendocrine tumors.

Authors:  Roberta Elisa Rossi; Sara Massironi; Dario Conte; Maddalena Peracchi
Journal:  Ann Transl Med       Date:  2014-01

7.  Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor.

Authors:  Alessia Di Florio; Veronica Sancho; Paola Moreno; Gianfranco Delle Fave; Robert T Jensen
Journal:  Biochim Biophys Acta       Date:  2012-12-04

Review 8.  Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances.

Authors:  Tetsuhide Ito; Hisato Igarashi; Robert T Jensen
Journal:  J Gastroenterol       Date:  2012-08-11       Impact factor: 7.527

9.  Lymph nodes and survival in pancreatic neuroendocrine tumors.

Authors:  Geoffrey W Krampitz; Jeffrey A Norton; George A Poultsides; Brendan C Visser; Lixian Sun; Robert T Jensen
Journal:  Arch Surg       Date:  2012-09

10.  Eastern Canadian Gastrointestinal Cancer Consensus Conference 2014.

Authors:  E Tsvetkova; S Sud; N Aucoin; J Biagi; R Burkes; B Samson; S Brule; C Cripps; B Colwell; C Falkson; M Dorreen; R Goel; F Halwani; J Maroun; N Michaud; M Tehfe; M Thirlwell; M Vickers; T Asmis
Journal:  Curr Oncol       Date:  2015-08       Impact factor: 3.677
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.